Cancer research

Accelerating Research to Improve Health

The UCSF Clinical and Translational Science Institute (CTSI) is part of the Clinical and Translational Science Award (CTSA) program funded by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) (Grant Number UL1 TR001872). The content of this website is solely the responsibility of CTSI and does not necessarily represent the official views of the NIH.

Cite CTSI NIH Funding Acknowledgment: Important — All publications resulting from the utilization of CTSI resources are required to credit the CTSI grant by including the NIH Funding acknowledgment and must comply with NIH Public Access Policy.

Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2.

Constitutive activation of Stat5b contributes to carcinogenesis in vivo.

Constitutive activation of Stat5b contributes to carcinogenesis in vivo.

Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.

Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.

Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.

Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.

Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation.

Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation.

Nuclear location and cell cycle regulation of the BRCA2 protein.

Pages

Search form

You are here

Cancer research

Pages